Philips announced a recall for millions of their Bi-Level Positive Airway Pressure (Bi-Level PAP), Continuous Positive Airway Pressure (CPAP), and mechanical ventilator devices in 2021.

"Philips Respironics will continue to prioritize completing the remediation of the sleep and respiratory care devices under Respironics’ voluntary June 2021 recall," Phillips said in a statement.

Starting in 2021, Philips launched a series of product recalls affecting its Respironics range of ventilators and other respiratory machines; most recently, a Class I recall of around 63,000 ...

Philips will no longer sell its Tack endovascular system in the US following a Class I recall by the US Food and Drug Administration (FDA). Class I is the most serious designation for a recall ...

Exor bought an initial 15.1% stake in Philips in August 2023, a boost at a time when the company was still grappling with a huge product recall dating back to 2021. In the year following that ...

During its first-quarter earnings report this spring, Philips, the health technology company, announced it agreed to pay $1.1 billion in a settlement over respiration and sleep apnea machines.

Exor bought an initial 15.1% stake in Philips in August 2023, a boost at a time when the company was still grappling with a huge product recall dating back to 2021. In the year following that ...